Can a history of treated pulmonary (pulm) coccidioidomycosis explain the incidental findings of a borderline dilated ascending aorta, an irregular nodule, and ground-glass opacities in the right lower lobe on a computed tomography (CT) calcium score in a 53-year-old male (M)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The imaging findings of a nodule and ground glass opacities in the right lower lobe could potentially be related to the patient's history of pulmonary coccidioidomycosis, but this cannot be definitively determined from the CT findings alone, and thus a follow-up CT in 3-6 months is recommended to monitor these findings. Treated coccidioidomycosis can leave residual nodules or scarring in the lungs, which might explain the 8 x 5 mm nodule, as noted in the guidelines for coccidioidomycosis management 1. However, the ground glass opacities in a centrilobular distribution are more suggestive of active processes like aspiration or infectious bronchiolitis, as noted in the report. The American College of Radiology (ACR) Appropriateness Criteria for incidentally detected indeterminate pulmonary nodules recommends follow-up tests in patients with an estimated lung cancer risk of 1% or higher, and allows flexibility to accommodate a patient’s risk factors and preferences in management 1. Given the patient's age and history, a pulmonology consultation would be beneficial to correlate these findings with clinical symptoms and determine if any additional workup or treatment is needed beyond the recommended follow-up imaging. The dilated ascending aorta (4.0 cm) is likely unrelated to the lung findings or coccidioidomycosis history and represents a separate incidental finding that may require its own follow-up.

Some key points to consider in the management of this patient include:

  • The patient's history of pulmonary coccidioidomycosis and the potential for residual lung abnormalities
  • The presence of a nodule and ground glass opacities in the right lower lobe, which may be related to the patient's history or may represent a new process
  • The recommendation for follow-up CT in 3-6 months to monitor these findings and ensure they are stable or resolving
  • The potential need for a pulmonology consultation to correlate these findings with clinical symptoms and determine if any additional workup or treatment is needed.

It is also important to note that the guidelines for coccidioidomycosis management emphasize the importance of establishing an etiologic diagnosis and explaining the natural history of the illness to the patient, as well as monitoring for potential complications 1. In this case, the patient's history of pulmonary coccidioidomycosis and the presence of residual lung abnormalities highlight the need for ongoing monitoring and follow-up to ensure that any new or worsening symptoms are promptly evaluated and addressed.

From the Research

Imaging Findings

The patient's imaging findings include:

  • Borderline dilated ascending aorta measuring 4.0 cm
  • Irregular nodule measuring 8 x 5 mm in the right lower lobe
  • Ground-glass opacities in a centrilobular distribution in the right lower lobe These findings may be related to aspiration or infectious bronchiolitis, and a CT follow-up is recommended in 3-6 months.

History of Pulmonary Coccidioidomycosis

The patient has a history of pulmonary coccidioidomycosis that was treated in the past.

  • According to 2, pulmonary coccidioidomycosis can manifest as acute, disseminated, or chronic forms, each with a spectrum of imaging findings.
  • The study by 3 found that chronic pulmonary coccidioidomycosis can present with solitary nodules, ground-glass attenuation, or consolidation on CT scans.
  • The patient's current imaging findings, such as the irregular nodule and ground-glass opacities, could be related to residual or chronic changes from the previous coccidioidomycosis infection, as described in 4 and 3.

Possible Explanation

The patient's history of pulmonary coccidioidomycosis could explain the current imaging findings, as:

  • Residual nodules and chronic changes are common in patients with a history of coccidioidomycosis, as mentioned in 2 and 4.
  • The ground-glass opacities and irregular nodule could be related to granulomatous inflammation or necrotizing granulomas, which are characteristic of chronic coccidioidomycosis, as described in 3. However, the possibility of other conditions, such as aspiration or infectious bronchiolitis, cannot be ruled out without further evaluation, as suggested in 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pulmonary coccidioidomycosis: pictorial review of chest radiographic and CT findings.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2014

Research

Chronic pulmonary coccidioidomycosis: computed tomographic and pathologic findings in 18 patients.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes, 1998

Research

Pulmonary coccidioidomycosis.

Seminars in respiratory and critical care medicine, 2008

Research

Update on the diagnosis of pulmonary coccidioidomycosis.

Annals of the American Thoracic Society, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.